Supporting Treatment Adherence for Resilience and Thriving
This Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.
• Assigned male at birth;
• Identifies as male;
• Age 18 or older;
• reads and speaks English;
• Continental US residency;
• Reports any anal sex with a man in the past year;
• Currently has an active Antiretroviral Therapy (ART) prescription and reports less than excellent ART adherence (past 30 days);
• Screens positive for a moderate or severe stimulant use disorder with an abbreviated version of the National Institute on Drug Abuse (NIDA)-modified Alcohol, Smoking and Substance. Involvement Screening Test (ASSIST);
• Has an iPhone or Android smartphone;
• Is willing to participate in an mHealth intervention;
• Is willing to provide a Dried Blood Spot (DBS) specimen for viral load testing